Efficacy of a Homeopathic Medicine of Capsicum frutescens L. (Solanaceae) in the Treatment of Hot Flashes in Menopausal Women: A Phase-2 Randomized Controlled Trial

被引:6
作者
da Silva Andrade, Debora Cristiane [1 ]
Carmona, Fabio [1 ]
Angelucci, Mateus Andrea [1 ]
Martinez, Edson Zangiacomi [2 ]
Soares Pereira, Ana Maria [3 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Ave Bandeirantes S-N,Campus Univ, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, Sao Paulo, SP, Brazil
[3] Univ Ribeirao Preto UNAERP, Dept Plant Biotechnol, Ribeirao Preto, Brazil
关键词
menopause; hot flashes; pepper; Solanaceae; homeopathy; SYMPTOMS;
D O I
10.1055/s-0038-1676326
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background Hot flashes are common in women during menopause, and are an important cause of discomfort, increasing the number of medical appointments. Hormone replacement therapy is an effective treatment, but it can bring undesirable consequences. Alternative treatments exist but they are not universally accepted or effective. The ingestion of malagueta peppers (popular name for fruits of Capsicum frutescens L, Solanaceae) causes sensations similar to those experienced by women during hot flashes. Using the homeopathic law of similars (let like be cured by like), we hypothesized that a homeopathic remedy made of malagueta peppers can be effective in alleviating menopausal hot flashes. We named this remedy Malagueta. Methods This randomized, placebo-controlled, double-blind, phase-2 clinical trial was designed to test the hypothesis that, in menopausal women, the homeopathic medicine Malagueta (30 CH), compared with placebo, will significantly reduce the intensity of hot flashes, after 4 weeks of treatment. The primary outcome was the intensity of hot flashes, measured by the Measure Yourself Medical Outcome Profile (MYMOP) instrument. A total of 40 women were enrolled in the study, 20 in each group. Results The effect of Malagueta on the primary outcome, the intensity of hot flashes, assessed by MYMOP, was superior to that of placebo over the 4 weeks of treatment, with worsening in both groups after treatment was interrupted (after week 4, p < 0.001 in ordinal logistic regression). The odds ratio for treatment response (reduction of at least three MYMOP categories) was 2.78 (95% confidence interval, 0.77 to 10.05). Treatment with Malagueta, compared with placebo, also reduced the intensity of the secondary symptoms (p = 0.001) and improved level of activity (p = 0.025) and well-being (p = 0.008). Conclusion The homeopathic medicine of Capsicum frutescens (Malagueta) was superior to placebo in reducing the intensity of hot flashes in menopausal women after 4 weeks of treatment.
引用
收藏
页码:102 / 107
页数:6
相关论文
共 19 条
[1]  
[Anonymous], 2011, BRAZ HOM PHARM
[2]  
[Anonymous], 1996, HERBAL MED GUIDE HLT
[3]  
Blumenthal M., 1998, COMPLETE GERMAN COMM
[4]   Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT [J].
Dean, M. E. ;
Coulter, M. K. ;
Fisher, P. ;
Jobst, K. ;
Walach, H. .
HOMEOPATHY, 2007, 96 (01) :42-45
[5]   Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging [J].
Harlow, Sioban D. ;
Gass, Margery ;
Hall, Janet E. ;
Lobo, Roger ;
Maki, Pauline ;
Rebar, Robert W. ;
Sherman, Sherry ;
Sluss, Patrick M. ;
de Villiers, Tobie J. .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (04) :387-395
[6]  
Harlow SD, 2012, CLIMACTERIC, V15, P105, DOI [10.1210/jc.2011-3362, 10.3109/13697137.2011.650656, 10.1016/j.fertnstert.2012.01.128, 10.1097/gme.0b013e31824d8f40]
[7]   Homeopathy for menopausal symptoms in breast cancer survivors: A preliminary randomized controlled trial [J].
Jacobs, J ;
Herman, P ;
Heron, K ;
Olsen, S ;
Vaughters, L .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2005, 11 (01) :21-27
[8]   Menopausal Hot Flashes: A Review of Physiology and Biosociocultural Perspective on Methods of Assessment [J].
Kronenberg, Fredi .
JOURNAL OF NUTRITION, 2010, 140 (07) :1380S-1385S
[9]  
Paterson C, 1996, BRIT MED J, V312, P1016
[10]  
Paterson C, 2000, J Health Serv Res Policy, V5, P27